In contrast, the expression of lipid oxidation genes was unaltered by MYDGF intervention, indicating that lipid lipolysis is not involved in the beneficial effects of MYDGF observed in NAFLD. Here, MYDGF is linked to metabolic dysfunction-associated steatotic liver disease.